Preventive effect of soybean resistant proteins against experimental tumorigenesis in rat colon.
The insoluble 'high-molecular-weight' fraction (HMF) centrifugally separable after digestion of soy protein isolate with a microbial protease of the exo-type, of which about a quarter is regarded as an indigestible 'resistant protein,' was examined for its preventive effect against colonic tumorigenesis in a model system with male F-344 rats. The rats were intraperitoneally injected with azoxymethane (15 mg/kg BW) once a week for 3 wk and were fed a 20.6% HMF diet (+0.4% DL-Met) or 14.7% casein diet (+0.3% DL-Met) supplemented with 0.2% sodium deoxycholate (DCA) or without supplementation. Twelve wk later, 5 rats of each group were inspected for formation of tumors but no tumors were visible to the naked eye. The DCA-fed casein group was conspicuous for a low count of aberrant crypt foci. At 39 wk, 6 rats of the DCA-fed casein group (n = 10) and 3 rats of the DCA-fed HMF group (n = 9) had a total of 18 tumors with a major axis of 4.0 +/- 0.4 mm and 3 tumors with an axis of 2.0 +/- 0.1 mm, respectively, in contrast to only a single tumor for the DCA-unfed casein group (nil for the DCA-unfed HMF group). The difference in tumor number and size was considered significant between these DCA-fed casein and HMF groups; that is to say, HMF feeding retarded tumor development despite the frequent occurrence of pre-neoplastic lesions. In addition, fecal bile acid excretion was much more elevated by HMF feeding than by casein feeding. It can be assumed from these observations that the antitumorigenicity of HMF is due to the inhibitory effect of soybean resistant proteins on reabsorption as well as the mucosal contact of bile acids in the intestine.
Azuma
N
N
Department of Biological Resource Chemistry, Kyoto Prefectural University, Japan.
Machida
K
K
Saeki
T
T
Kanamoto
R
R
Iwami
K
K
D000818:Animals; D001397:Azoxymethane; D001647:Bile Acids and Salts / Q000378:metabolism; D002273:Carcinogens; D002364:Caseins / Q000008:administration & dosage; D002784:Cholesterol / Q000097:blood; D003110:Colonic Neoplasms / Q000139:chemically induced / Q000473:pathology* / Q000517:prevention & control; D003840:Deoxycholic Acid / Q000008:administration & dosage; D005243:Feces / Q000737:chemistry; D008055:Lipids / Q000032:analysis; D008297:Male; D008970:Molecular Weight; D011230:Precancerous Conditions / Q000139:chemically induced / Q000473:pathology* / Q000517:prevention & control; D051381:Rats; D011916:Rats, Inbred F344; D030262:Soybean Proteins / Q000008:administration & dosage* / Q000737:chemistry / Q000627:therapeutic use; D013256:Steroids / Q000032:analysis
D001647:Bile Acids and Salts; D002273:Carcinogens; D002364:Caseins; D008055:Lipids; D030262:Soybean Proteins; D013256:Steroids; D003840:Deoxycholic Acid; D002784:Cholesterol; D001397:Azoxymethane